- Report
- March 2025
- 176 Pages
Global
From €4279EUR$4,900USD£3,717GBP
- Report
- August 2025
- 195 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 192 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 88 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- December 2022
- 172 Pages
Global
From €2052EUR$2,350USD£1,783GBP
- Report
- August 2022
- 160 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- April 2023
- 114 Pages
Global
From €4148EUR$4,750USD£3,604GBP
- Report
- October 2023
- 145 Pages
Global
From €2751EUR$3,150USD£2,390GBP
- Report
- November 2021
- 656 Pages
Global
From €4367EUR$5,000USD£3,793GBP
The Proteomic Platform market is a subset of the larger Genomics market. It focuses on the analysis of proteins, which are the building blocks of life. Proteomic Platforms are used to identify, quantify, and characterize proteins in a variety of biological samples. This technology is used to study the structure and function of proteins, as well as to identify biomarkers for disease diagnosis and drug development.
Proteomic Platforms are used in a variety of research and clinical applications, including drug discovery, biomarker discovery, and disease diagnosis. Companies in the Proteomic Platform market include Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, and Bruker Corporation. Show Less Read more
